Security key
87650L103
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 40,066,753
- Total 13F value
- $1,089,006,566
- Share change
- +736,134
- Put/Call ratio
- 2132%
- SEC-reported price per share
- $27.18
- Number of holders
- 147
- Value change
- +$6,596,629
- Number of buys
- 91
- Number of sells
- 75
- Shares outstanding
- 42,282,321
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
147
Top holders
10
TARS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Tarsus Pharmaceuticals, Inc. SEC filings
Tarsus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87650L103
Recent filing periods:
Ownership snapshot
Top reported holders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
3/4/5
Lead comparable stake: 7.7%
Showing 1-6 of 15 holder rows.
Quick read
RTW INVESTMENTS, LP leads the comparable SEC ownership view at 7.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership
Top 5
RTW INVESTMENTS, LP
7.7%
Paradigm Biocapital Advisors LP
6.8%
BlackRock Finance, Inc.
6.3%
MORGAN STANLEY
5.7%
TANG CAPITAL MANAGEMENT LLC
5.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
3/4/5
Company · 10%+ Owner
|
7.7%
|
$118,949,595
3,272,341 shares
|
— | 31 Mar 2024 |
| Paradigm Biocapital Advisors LP |
13F
Company
|
6.8%
|
$104,084,808
2,863,406 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
6.3%
|
$96,424,917
2,652,680 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
5.7%
|
$87,200,670
2,398,918 shares
|
— | 31 Mar 2024 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
5.3%
|
$81,961,871
2,254,797 shares
|
— | 31 Mar 2024 |
| Cormorant Asset Management, LP |
13F
Company
|
5.1%
|
$77,756,358
2,139,102 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
147
Shares
40,066,753
Rows available
147
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
155
Q2 2024 holders
147
Holder diff
-8
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend